Founded in 2010, InnoStar has successfully supported global pharmaceutical and biotech companies with drug discovery, ADME, PK/PD, toxicology, biomarkers, and bioanalysis services. With state-of-the-art facilities across China and the U.S. and a team of over 1,000 scientists, we have enabled hundreds of IND and NDA/BLA approvals worldwide.
InnoStar is GLP-certified by multiple international authorities, including the U.S. FDA, NMPA, and OECD, ensuring compliance with global regulatory standards. Our mission is to accelerate innovative drug development and support our clients in bringing life-saving therapies to patients worldwide.
3. Service experience
We have completed over 13,700 projects for more than 770 sponsors. These studies have been submitted in support of over 370 INDs and 18 NDAs/BLAs for innovative drugs in China and 2 NDAs/BLAs in the United States, over 90 INDs in the United States, the European Union, South Korea, and Australia, etc.
Data updated to: Dec 31, 2023
InnoStar is committed to providing one-stop service solutions to our sponsors in China and abroad. We are striving to be the scientific and technological innovation pioneer, new drug R&D accelerator, and human life and health guardian.
InnoStar was listed on the STAR Market of Shanghai Stock Exchange on September 3, 2024 (Stock code: 688710).
Company Details
- Employees
- 23
- Founded
- -
- Address
- 199 Guoshoujing Rd, Shanghai,china
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.innostar.cn/en/
- Keywords
- Pharmacodynamics, Pharmacokinetics, CRO, New Drug R&D, Druggability Assessment, Nonclinical Assessment, Safety Evaluation, New Drug Registration, Small Molecules, ADC, Peptide Drugs, PROTAC, Antibody Drugs, Molecular Glues, Therapeutic Vaccines, Cell and Gene Therapeutics, Prophylactic Vaccine, Monkey study, Toxicology study, Radiopharmaceutical, animal models, drug discovery, drug screening, disease models, bioanalysis, biomarker study, nonhuman primates.
- HQ
- Shanghai
Innostar Questions
Innostar's website is http://www.innostar.cn/en/
Innostar's LinkedIn profile is https://www.linkedin.com/company/innostar-us
Innostar has
23 employees.
View email and phone details for 23
employees at Innostar.
Innostar's industry is
Pharmaceutical Manufacturing
Innostar's top competitors are
Necina,
上海益诺思生物技术股份有限公司,
Biocytogen,
Medicilon Inc.,
Shanghai Innostar Biotech,
Aragen Life Sciences,
Porton Advanced | Atmp Cdmo/cro,
Wuxi Xdc,
The Whiteoak Group, Inc.,
Hitchem.
Innostar's categories are Pharmaceutical Manufacturing
Innostar's founding year is 2010
